Xiaoqing Xiong
Nanjing, 211166, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Therapeutic potential of ELABELA in alleviating hereditary hypertrophic cardiomyopathy.
Journal: Journal of advanced research
Published: March 25, 2026
ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: March 05, 2026
Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) inhibitors reduce vascular inflammation in vitro and in vivo.
Journal: British journal of pharmacology
Published: January 04, 2024
Aberrant splicing of CaV1.2 calcium channel induced by decreased Rbfox1 enhances arterial constriction during diabetic hyperglycemia.
Journal: Cellular and molecular life sciences : CMLS
Published: October 22, 2023
Angiotensin II-induced miR-31-5p upregulation promotes vascular smooth muscle cell proliferation and migration.
Journal: Experimental cell research
Published: May 20, 2022
Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects.
Journal: Acta pharmacologica Sinica
Published: September 08, 2021
Effect of characteristics of different wheat flours on the quality of fermented hollow noodles.
Journal: Food science & nutrition
Published: September 18, 2020
Intermedin in Paraventricular Nucleus Attenuates Ang II-Induced Sympathoexcitation through the Inhibition of NADPH Oxidase-Dependent ROS Generation in Obese Rats with Hypertension.
Journal: International journal of molecular sciences
Published: July 23, 2019
FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress.
Journal: Journal of translational medicine
Published: December 18, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026